Skip to main content
OpenTrials
Completed

NCT Number: NCT02192437

Dietary Methionine and Cysteine Restriction in Healthy Adults

Studies in laboratory models indicate that dietary methionine restriction (MR) enhances longevity and produces short- and long-term metabolic changes that are consistent with a healthy lifespan. The present study was designed to establish levels of dietary methionine or methionine and cysteine that induce physiological changes in healthy adults like those observed in rodent studies .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

24 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Penn State University

State College, Pennsylvania, 16802, United States

About this study

In this controlled feeding study, subjects will be randomized to one of two experimental. Group A (N=10): will start with control diet (31 mg/kg/day Met; 31 mg/kg/day Cys) for 4 weeks followed by a washout for 3-4 weeks, then a 70% MR diet (9.3 mg/kg/day Met; 40.3 mg/kg/day SAA) for 4 weeks, followed by 3-4 weeks washout period and then a 90% MR diet (3.1 mg/kg/day Met; 34.1 mg/kg/day SAA) for 4 weeks. Group B (N=10): will start with control diet (31 mg/kg/day Met; 31 mg/kg/day Cys) for 4 weeks followed by a washout for 3-4 weeks then a 50% methionine and cysteine restricted (M/CR) diet (15.5 mg/kg/day Met; 15.5 mg/kg/day Cys; 31 mg/kg/day SAA), followed by 3-4 weeks washout period and then a 65% M/CR diet (10.8 mg/kg/day Met; 10.8 mg/kg/day Cys; 21.6 mg/kg/day SAA) for 4 weeks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy English speaking male and female volunteers
  • May or may not be students
  • Age range 24-65 years
  • Subjects will need to be of normal weight or moderately overweight (BMI 18.5-35 kg/m2)
  • Subjects will be non-smokers

Exclusion criteria

  • No use of medications known to impact the biomarkers of interest
  • Pregnancy and lactating women
  • Persons with documented diabetes
  • No use of high dose dietary antioxidant supplements or fish oil/flax seed oil for n-acetylcysteine for at least 1 month prior to the study
  • Use of tobacco products over the past 6 months
  • Unstable weight
  • Individuals with allergies to eggs, wheat, nuts, soy and latex
  • Individuals with phenylketonuria (PKU)

Treatment and study plan

Sulfur amino acid restricted diet

Other

Methionine restricted diet: 70% or 90% restriction Methionine and cysteine restricted diet: 50% or 65% restriction

Primary outcomes

  1. Body weight, plasma sulfur amino acids

    Time frame: Baseline, four weeks

Secondary outcomes

  1. Biomarkers of oxidative stress, blood lipids

    Time frame: Baseline, four weeks

Other outcomes

  1. Plasma IGF1, insulin

    Time frame: Baseline, four weeks

Sponsors and collaborators

Lead sponsor

Milton S. Hershey Medical Center

Other

Collaborators

  • Orentreich Foundation for the Advancement of Science, Inc.

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
Jul 16, 2014
Registry last updated
Sep 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.